The present study showed that genetic variability in CALB2 gene and genes coding for transcription factors and miRNAs that regulate calretinin expression could contribute to interindividual differences in serum calretinin levels in MM patients or asbestos-exposed subjects. The gene discussed is CALB2; the disease is Miyoshi myopathy.